Amarin | AMRN - EPS Earnings Per Share


Amarin reported $0.14 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.





Eps Change Date
AbbVie USD 3.82 0.17 Sep/2026
Alnylam Pharmaceuticals USD 16.26 14.42 Sep/2026
Amarin USD 0.14 0.06 Dec/2025
AstraZeneca USD 2.79 0.16 Sep/2026
BioCryst Pharmaceuticals USD 0.3 0.87 Jun/2026
DBV Technologies USD -0.7 0.15 Sep/2026
GlaxoSmithKline GBP 0.55 0.04 Sep/2026
Halozyme Therapeutics USD 2.39 0.11 Sep/2026
Heron Therapeutics USD -0.02 0.02 Dec/2025
Ionis Pharmaceuticals USD 0.66 1.35 Sep/2026
Nektar Therapeutics USD -1.78 0.43 Mar/2026
Neurocrine Biosciences USD 3.29 0.44 Sep/2026
Novartis USD 2.46 0.05 Sep/2026